On May 4th, 2020, part 1 of a documentary series called Plandemic (which featured an interview with whistleblower Dr Judy Mikovits) was released. Analysis by multiple independent groups have estimated that Part 1 has received “over one billion views,” making it the most viewed and banned documentary of all time. Dr. Judy Mikovits is a modern-day Rosalind Franklin, a brilliant researcher shaking up the old boys’ club of science with her ground-breaking discoveries. And like many women who have trespassed into the world of men, she uncovered decades old secrets that many would prefer to stay buried. JUDY A. MIKOVITS, PHD Dr. Judy A. Mikovits earned her BA in chemistry with a specialization in biology from the University of Virginia in 1980 and her PhD in biochemistry and molecular biology from George Washington University in 1992. In her 35-year quest to understand and treat chronic diseases, she has co-authored seminal papers culminating at least a decade of research in each of four fields: immunology, natural products chemistry, epigenetics, and HIV/AIDs drug development. In 2006, she became attracted to the plight of families with neuroimmune diseases including ME/CFS and autism. Dr. Mikovits has been primarily responsible for demonstrating the relationship between environmentally acquired immune dysfunction, chronic inflammation, and these diseases. Dr. Mikovits has published more than 50 peer-reviewed articles, many in the world’s top medical journals and she has been profiled in Discover magazine as well as the Wall Street Journal and The New York Times. Her pioneering work during her 20-year career at the National Cancer Institute includes the discovery of the modulation of DNA methylation machinery by human retro viral infection and the development of the concept of inflammatory cytokines and chemokine signatures of infection and disease, which was first published in 1999, when she directed the Laboratory of Antiviral Drug Mechanisms in developing therapeutics and diagnostics for HIV/AIDS and AIDS associated malignancies. These are all therapies that are still the standard of care twenty-five years later and credited with saving millions of deaths from HIV/AIDS. Website Link: